NPT1220-478 IV formulation

N/A

Report date: 2024/11/04 15:47:34
NME

Base Information

Drug NameNPT1220-478 IV formulation
Drug Alias NameNPT1220-478
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 inhibitorsToll like receptor 9 antagonists
TargetsToll like receptor 2Toll like receptor 9
Therapy Area/IndicationsGuillain-Barre Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuropore Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuropore Therapies Inc
Inactive CompaniesN/A
Active IndicationsGuillain-Barre Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A